University Hospitals Cleveland Medical Center /ID# 283527 — Cleveland, Ohio

University Hospitals Cleveland Medical Center /ID# 283527 is a clinical research site located in Cleveland, Ohio, United States 44106.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

University Hospitals Cleveland Medical Center /ID# 283527 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cleveland

Browse all research sites in Ohio · View every site in Cleveland

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University Hospitals Cleveland Medical Center /ID# 283527?

University Hospitals Cleveland Medical Center /ID# 283527 has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University Hospitals Cleveland Medical Center /ID# 283527 conducted?

University Hospitals Cleveland Medical Center /ID# 283527 has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory Multiple Myeloma.

Is University Hospitals Cleveland Medical Center /ID# 283527 accredited by Crixeo Clinical Trials?

University Hospitals Cleveland Medical Center /ID# 283527 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University Hospitals Cleveland Medical Center /ID# 283527?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.